NCT03623217View on ClinicalTrials.gov

Quality of Life Questionnaire Validation for Patients With Changed Tacrolimus Dosing After Kidney Transplantation

CompletedOBSERVATIONAL
Enrollment

56

Participants

Timeline

Start Date

February 24, 2015

Primary Completion Date

October 17, 2017

Study Completion Date

October 17, 2017

Conditions
Kidney Transplantation
Interventions
BEHAVIORAL

Qualitative interviews with participants

For the development and validation of a questionnaire.

Trial Locations (1)

06351

Site 1, Seoul

All Listed Sponsors
lead

Astellas Pharma Korea, Inc.

INDUSTRY

NCT03623217 - Quality of Life Questionnaire Validation for Patients With Changed Tacrolimus Dosing After Kidney Transplantation | Biotech Hunter | Biotech Hunter